gemcitabine

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

Not yet recruiting
  • Hydroxychloroquine
  • +2 more
  • Hydroxychloroquine Combined With Gemcitabine
  • (no location specified)
Dec 3, 2022

Gemcitabine, Biliary Tract Cancer, Immune Checkpoint Inhibitors Trial in Hangzhou (Gemcitabine-based chemo regimen combined with

Not yet recruiting
  • Gemcitabine
  • +2 more
  • Gemcitabine-based chemotherapy regimen combined with immunocheckpoint inhibitors
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Aug 2, 2022

Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)

Not yet recruiting
  • Urothelial Carcinoma
  • +6 more
  • Tianjin, China
    Tianjin Medical Unversity Second Hospital
Aug 30, 2021

Cholangiocarcinoma, Biliary Tract Cancer, Adjuvant Chemo Trial in Seoul (Gemcitabine plus cisplatin, Capecitabine)

Recruiting
  • Cholangiocarcinoma
  • +5 more
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 13, 2020

Pancreatic Cancer, Nab-paclitaxel, Gemcitabine Trial in Wuhan (S1 or Gemcitabine)

Unknown status
  • Pancreatic Cancer
  • +3 more
  • S1 or Gemcitabine
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Jul 4, 2019

PTCL, Gemcitabine Trial in Jinan

Unknown status
  • PTCL
  • Gemcitabine
    • Jinan, Shandong, China
      Yujie MS JIANG
    Mar 19, 2019

    Chidamide, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse Trial in Shanghai (Chidamide combined with R-GDP)

    Unknown status
    • Chidamide
    • +15 more
    • Chidamide combined with R-GDP
    • Shanghai, Shanghai, China
    • +1 more
    Dec 12, 2017

    Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer, Gemcitabine, Maintenance Chemo Trial in Xi'an

    Unknown status
    • Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer
    • +2 more
      • Xi'an, Shaanxi, China
        Xijing Hospital , Fourth Military Medical University
      Jul 10, 2014

      Advanced Biliary Tract Adenocarcinoma, Gemcitabine, Oxaliplatin Trial in Bucheon (Gemcitabine and Oxaliplatin)

      Completed
      • Advanced Biliary Tract Adenocarcinoma
      • +4 more
      • Gemcitabine and Oxaliplatin
      • Bucheon, Kyunggi, Korea, Republic of
        Soonchunhyang University Bucheon Hospital
      May 19, 2014